40
Views
14
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Juvenile dermatomyositis: clinical characteristics and the relatively high risk of interstitial lung disease

, , &
Pages 413-417 | Received 12 Jan 2007, Accepted 13 Jun 2007, Published online: 02 Jan 2014

References

  • Pachman LM, Hayford JR, Chung A, Daugherty CA, Pallansch MA, Fink CW, et al. Juvenile dermatomyositis at diagnosis: Clinical characteristics of 79 children. J Rheumatol 1998;25:1198–234.
  • Huber AM, Lang B, LeBlanc CM, Birdi N, Bolaria RK, Malleson P, et al. Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis. Arthritis Rheum 2000;43:541-9. Table 3. Incidence of juvenile dermatomyositis-associated interstitial lung disease First authorRef. Year No. of JDM No. of ILD (dead) Incidence of ILD Kikuchi10 1985 68 1 (0) 1.5% Hiketa9 1992 29 0 0.0% Kobayashi11 1997 102 4 3.9% Higuchi22 1997 22 1 (1) 4.6% Ito19 1998 11 0 0.0% Kobayashi6 2003 10 5 (1) 50.0% Present study 16 3 (1) 18.8% JDM, juvenile dermatomyositis; ILD, interstitial lung disease
  • Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med 1975;292:344–7.
  • Tanimoto K, Kano S, Nakano K, Nishitani H, Sato T. Revised diagnostic criteria of dermatomyositis/polymyositis (in Japanese). Annual Report: The Ministry of Health and Welfare of Japan, Results of a study in 1992. 1993; p. 25–8.
  • Kohno N, Kyoizumi S, Awaya Y, Fukuhara H, Yamakido M, Akiyama M. New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6. Chest 1989;96:68–73.
  • Kobayashi I, Yamada M, Takahashi Y, Kawamura N, Okano M, Sakiyama Y, et al. Interstitial lung disease associated with juvenile dermatomyositis: clinical features and effi cacy of cyclosporin A. Rheumatology 2003;42:371–4.
  • Al-Salmi QA, Walter JN, Colasurdo GN, Sockrider MM, Smith EO, Takahashi H, et al. Serum KL-6 and surfactant proteins A and D in pediatric interstitial lung disease. Chest 2005;127: 403–7.
  • Kobayashi I, Ono S, Kawamura N, Okano M, Miyazawa K, Shibuya H, et al. KL-6 is a potential marker for interstitial lung disease associated with juvenile dermatomyositis. J Pediatr 2001;138: 274–6.
  • Hiketa T, Matsumoto Y, Ohashi M, Sasaki R. Juvenile dermatomyositis: A statistical study of 114 patients with dermatomyositis. J Dermatol 1992;19:470–6.
  • Kikuchi R, Arai Y, Kaneko K, Hidano A. Survey of 68 cases of childhood dermatomyositis, especially on its prognosis. J Pediatr Dermatol 1985;4:507–11.
  • Kobayashi S, Higuchi K, Tamaki H, Wada Y, Wada N, Kubo M, et al. Characteristics of juvenile dermatomyositis in Japan. Acta Paediatr Jpn 1997;39:257–62.
  • Tomono N, Mori M, Nakajima S, Miyamae T, Ito S, Mitsuda T, et al. HLA-DRB1*15021 is the predominant allele in Japanese patients with juvenile dermatomyositis. J Rheumatol 2004;31: 1847–50.
  • Callen JP. Dermatomyositis. Lancet 2000;355:53–7.
  • Norins AL. Juvenile dermatomyositis. Med Clin North Am 1989;73:1193–239.
  • Ramanan AV, Feldman BM. Clinical features and outcomes of juvenile dermatomyositis and other childhood onset myositis syndromes. Rheum Dis Clin North Am 2002;28:833–57.
  • Winkelmann RK. Dermatomyositis in childhood. Clin Rheum Dis 1982;8:353–68.
  • Kimball AB, Summers RM, Turner M, Dugan EM, Hicks J, Miller FW, et al. Magnetic resonance imaging detection of occult skin and subcutaneous abnormalities in juvenile dermatomyositis. Implications for diagnosis and therapy. Arthritis Rheum 2000;43: 1866–73.
  • Tabarki B, Ponsot G, Prieur AM, Tardieu M. Childhood dermatomyositis: clinical course of 36 patients treated with low doses of corticosteroids. Eur J Paediatr Neurol 1998;2:235–11.
  • Ito S, Imagawa T, Miyamae T, Katakura S, Mori M, Tomono J, et al. Clinical analysis of 11 cases of juvenile dermatomyositis and polymyositis (in Japanese). Ryumachi 1998;38:785–92.
  • Schnabel A, Reuter M, Biederer J, Richter C, Gross WL. Interstitial lung disease in polymyositis and dermatomyositis: clinical course and response to treatment. Semin Arthritis Rheum 2003; 32:273–84.
  • Kameda H, Nagasawa H, Ogawa H, Sekiguchi N, Takei H, Tokuhira M, et al. Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute/ subacute interstitial pneumonia in patients with dermatomyositis. J Rheumatol 2005;32:1719–26.
  • Higuchi K, Wada N, Fukunaga K, Kobayashi S, Okabe N, Kubo M, et al. Childhood dermatomyositis: an analysis of clinical and laboratory features and the clinical course in 22 cases (in Japanese). Jpn J Pediatr 1997;50:465–70.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.